KDR and asthma: A recent study by Jiang et al. [90] demonstrated that the vascular endothelial growth factor (VEGF) receptor 2 (kinase insert domain receptor (KDR)) loss mediated Sox9 overexpression in airway mucous metaplasia in asthma and cystic fibrosis (CF) patients.